Overview
Carcinoma of the stomach, salivary gland type is a very rare and now considered an outdated (obsolete) classification of a stomach cancer that looks similar under the microscope to cancers that normally arise in the salivary glands. This means that when a pathologist examines the tumor tissue, the cancer cells have features that resemble salivary gland tumors — such as mucoepidermoid carcinoma or adenoid cystic carcinoma — rather than the typical stomach cancer cells. Because this classification has been retired or reorganized in current medical coding systems, it may now be described under more specific tumor type names depending on the exact cell pattern seen. This type of cancer affects the stomach, which is part of the digestive system. It can interfere with normal digestion, cause pain or discomfort in the upper abdomen, and lead to problems with eating and nutrition. Like other stomach cancers, it may spread to nearby lymph nodes or other organs if not caught early. Treatment generally follows the approach used for stomach (gastric) cancers and may include surgery to remove the tumor, chemotherapy, radiation therapy, or a combination of these. Because this is such a rare tumor type, treatment decisions are often made by a multidisciplinary team of specialists. Research into targeted therapies and immunotherapy for gastric cancers may also be relevant depending on the specific tumor characteristics found on testing.
Also known as:
Key symptoms:
Pain or discomfort in the upper abdomen or stomach areaFeeling full quickly after eating only a small amountNausea or vomitingUnintentional weight lossLoss of appetiteDifficulty swallowingBloating after mealsFatigue or low energyBlood in vomit or dark, tarry stools (a sign of bleeding)
Sporadic
Usually appears on its own, not inherited from a parent
Adult
Begins in adulthood (age 18 or older)
Treatments
No FDA-approved treatments are currently listed for OBSOLETE: Carcinoma of stomach, salivary gland type.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for OBSOLETE: Carcinoma of stomach, salivary gland type at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for OBSOLETE: Carcinoma of stomach, salivary gland type.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to OBSOLETE: Carcinoma of stomach, salivary gland type.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: Carcinoma of stomach, salivary gland type.
Start the conversation →Latest news about OBSOLETE: Carcinoma of stomach, salivary gland type
No recent news articles for OBSOLETE: Carcinoma of stomach, salivary gland type.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What is the exact subtype of my tumor, and how does that affect my treatment options?,Has my tumor been tested for HER2, MSI, and PD-L1, and what do those results mean for me?,What stage is my cancer, and what does that mean for my prognosis?,Should I seek a second opinion from a specialist center that has experience with rare stomach tumors?,Are there any clinical trials I might be eligible for given how rare this tumor type is?,How will treatment affect my ability to eat, and will I need to see a dietitian?,Should my family members be tested for any hereditary cancer risk?
Common questions about OBSOLETE: Carcinoma of stomach, salivary gland type
What is OBSOLETE: Carcinoma of stomach, salivary gland type?
Carcinoma of the stomach, salivary gland type is a very rare and now considered an outdated (obsolete) classification of a stomach cancer that looks similar under the microscope to cancers that normally arise in the salivary glands. This means that when a pathologist examines the tumor tissue, the cancer cells have features that resemble salivary gland tumors — such as mucoepidermoid carcinoma or adenoid cystic carcinoma — rather than the typical stomach cancer cells. Because this classification has been retired or reorganized in current medical coding systems, it may now be described under mo
How is OBSOLETE: Carcinoma of stomach, salivary gland type inherited?
OBSOLETE: Carcinoma of stomach, salivary gland type follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does OBSOLETE: Carcinoma of stomach, salivary gland type typically begin?
Typical onset of OBSOLETE: Carcinoma of stomach, salivary gland type is adult. Age of onset can vary across affected individuals.